NO773010L - Analogifremgangsmaate for fremstilling av fysiologisk aktive aryl-alkylaminer - Google Patents

Analogifremgangsmaate for fremstilling av fysiologisk aktive aryl-alkylaminer

Info

Publication number
NO773010L
NO773010L NO773010A NO773010A NO773010L NO 773010 L NO773010 L NO 773010L NO 773010 A NO773010 A NO 773010A NO 773010 A NO773010 A NO 773010A NO 773010 L NO773010 L NO 773010L
Authority
NO
Norway
Prior art keywords
preparation
physiologically active
active aryl
alkylamines
analogical procedure
Prior art date
Application number
NO773010A
Other languages
English (en)
Other versions
NO147911C (no
NO147911B (no
Inventor
Wolfgang Eberlein
Volkhard Austel
Joachim Heider
Juergen Daemmgen
Rudolf Kadatz
Christian Lillie
Walter Kobinger
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO773010L publication Critical patent/NO773010L/no
Publication of NO147911B publication Critical patent/NO147911B/no
Publication of NO147911C publication Critical patent/NO147911C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Electroluminescent Light Sources (AREA)
  • Testing Or Measuring Of Semiconductors Or The Like (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO773010A 1976-09-01 1977-08-31 Analogifremgangsmaate for fremstilling av fysiologisk aktive kinazolinon- og ftalazinon-derivater som er substituert med en substituert n-fenylalkylaminoalkylrest NO147911C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762639291 DE2639291A1 (de) 1976-09-01 1976-09-01 Neue aryl-alkylamine

Publications (3)

Publication Number Publication Date
NO773010L true NO773010L (no) 1978-03-02
NO147911B NO147911B (no) 1983-03-28
NO147911C NO147911C (no) 1983-07-06

Family

ID=5986872

Family Applications (1)

Application Number Title Priority Date Filing Date
NO773010A NO147911C (no) 1976-09-01 1977-08-31 Analogifremgangsmaate for fremstilling av fysiologisk aktive kinazolinon- og ftalazinon-derivater som er substituert med en substituert n-fenylalkylaminoalkylrest

Country Status (32)

Country Link
US (1) US4134980A (no)
JP (1) JPS5331685A (no)
AT (1) AT350058B (no)
AU (1) AU513302B2 (no)
BE (1) BE858309A (no)
BG (1) BG31378A3 (no)
CA (1) CA1085838A (no)
CS (1) CS197299B2 (no)
DD (1) DD133945A5 (no)
DE (1) DE2639291A1 (no)
DK (1) DK148684C (no)
ES (4) ES462005A1 (no)
FI (1) FI63025C (no)
FR (1) FR2363564A1 (no)
GB (1) GB1544880A (no)
GR (1) GR63624B (no)
HK (1) HK33582A (no)
HU (1) HU175549B (no)
IE (1) IE45672B1 (no)
IL (1) IL52853A (no)
LU (1) LU78049A1 (no)
MY (1) MY8300057A (no)
NL (1) NL7709577A (no)
NO (1) NO147911C (no)
NZ (1) NZ185061A (no)
PH (1) PH13994A (no)
PL (2) PL103691B1 (no)
PT (1) PT66975B (no)
RO (1) RO73286A (no)
SE (1) SE442866B (no)
SU (2) SU665802A3 (no)
ZA (1) ZA775262B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
IT1222867B (it) * 1987-10-12 1990-09-12 Zambon Spa Ftalazino derivati ad attivita' farmaceutica
IT1229118B (it) * 1988-07-29 1991-07-22 Simes Composti attivi sul sistema cardiovascolare che presentano sia la struttura dei beta-bloccanti sia una porzione calcio-antagonista
JP6895002B1 (ja) 2020-05-27 2021-06-30 ウィンボンド エレクトロニクス コーポレーション 半導体記憶装置および読出し方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2020234A1 (de) * 1970-04-25 1971-11-18 Cassella Farbwerke Mainkur Ag Basisch substituierte Derivate des 4(3H)-Chinazolinons
US3829420A (en) * 1970-07-13 1974-08-13 Sumitomo Chemical Co 3,4-dihydro-2(1h)-quinazolinones and preparation thereof
US3905976A (en) * 1971-11-24 1975-09-16 Sandoz Ag Substituted tricyclic quinazolinones

Also Published As

Publication number Publication date
GB1544880A (en) 1979-04-25
IE45672L (en) 1978-03-01
AT350058B (de) 1979-05-10
LU78049A1 (no) 1978-09-14
PT66975B (de) 1979-07-13
US4134980A (en) 1979-01-16
DE2639291C2 (no) 1987-05-27
NL7709577A (nl) 1978-03-03
ES465561A1 (es) 1978-09-16
SE7709816L (sv) 1978-03-02
HU175549B (en) 1980-08-28
FI63025C (fi) 1983-04-11
RO73286A (ro) 1981-08-17
SU665802A3 (ru) 1979-05-30
DK148684C (da) 1986-02-17
NO147911C (no) 1983-07-06
AU513302B2 (en) 1980-11-27
IL52853A0 (en) 1977-10-31
IL52853A (en) 1980-07-31
FR2363564B1 (no) 1981-05-29
PH13994A (en) 1980-11-28
JPS5331685A (en) 1978-03-25
FR2363564A1 (fr) 1978-03-31
PL103564B1 (pl) 1979-06-30
FI63025B (fi) 1982-12-31
BE858309A (fr) 1978-02-28
CA1085838A (en) 1980-09-16
ZA775262B (en) 1979-04-25
GR63624B (en) 1979-11-27
CS197299B2 (en) 1980-04-30
DE2639291A1 (de) 1978-03-02
PT66975A (de) 1977-09-01
ES465560A1 (es) 1978-09-16
SU837323A3 (ru) 1981-06-07
IE45672B1 (en) 1982-10-20
JPS613787B2 (no) 1986-02-04
ES462005A1 (es) 1978-06-16
DD133945A5 (de) 1979-01-31
PL200570A1 (pl) 1978-05-22
DK148684B (da) 1985-09-02
ATA600577A (de) 1978-10-15
DK367077A (da) 1978-03-02
PL103691B1 (pl) 1979-07-31
AU2842477A (en) 1979-03-08
NO147911B (no) 1983-03-28
SE442866B (sv) 1986-02-03
MY8300057A (en) 1983-12-31
BG31378A3 (bg) 1981-12-15
FI772261A (fi) 1978-03-02
NZ185061A (en) 1980-03-05
ES465562A1 (es) 1978-09-16
HK33582A (en) 1982-07-30

Similar Documents

Publication Publication Date Title
NO784211L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive acylanilid-derivater
NO784231L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive benzotiazinderivater
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO143219C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO773384L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO780883L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 4-acylamino-fenyl-etanolaminer
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
NO147986C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive fenyletylaminer
NO773327L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyrazolopyridiner
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO149428C (no) Fremgangsmaate for fremstilling av fysiologisk aktive prostaglandinderivater.
NO790523L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive 2-fenyliminoimidazolidiner
NO781878L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner.
NO781879L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO145540C (no) Fremgangsmaate for fremstilling av terapeutisk aktive polyribonukleotider
SE7607717L (sv) Analogiforfarande for framstellning av l-pyroglutamyl-l-prolinamid
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO145383C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler.
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
NO773344L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive pyridobenzodiazepinoner
NO784325L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater
NO773010L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive aryl-alkylaminer